Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWH

Healthcare Medical Devices
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (NDAQ:AWH)

Aspira Women's Health to Participate at William Blair's 43rd Annual Growth Stock Conference

GlobeNewswire May 30, 2023

Aspira Women's Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference

GlobeNewswire May 19, 2023

Aspira Women's Health Names Torsten Hombeck as Chief Financial Officer

GlobeNewswire May 16, 2023

Aspira Women's Health to Host Investor Day on OvaWatch(SM) and EndoCheck(TM) Market Opportunities on May 23, 2023

GlobeNewswire May 15, 2023

Aspira Women's Health® Reports First Quarter 2023 Financial Results

GlobeNewswire May 11, 2023

Aspira Women's Health Announces 1-for-15 Reverse Stock Split

GlobeNewswire May 11, 2023

Aspira Women's Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test

GlobeNewswire May 11, 2023

Aspira Women's Health Appoints Three New Members to its Board of Directors

GlobeNewswire May 9, 2023

Aspira Women's Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023

GlobeNewswire April 27, 2023

Aspira Women's Health Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 22, 2023

Aspira Women's Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023

GlobeNewswire March 3, 2023

Aspira Women's Health Announces National Payer Coverage for OvaWatch

GlobeNewswire March 3, 2023

Aspira Women's Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights

GlobeNewswire January 9, 2023

Aspira Women's Health Announces Publication of Real-World Data Validating Use of OvaWatch for the Management of Adnexal Masses

GlobeNewswire January 6, 2023

Aspira Women's Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing Portfolio

GlobeNewswire December 27, 2022

Aspira Women's Health Announces the Commercial Launch of OvaWatch(SM)

GlobeNewswire November 29, 2022

Aspira Women's Health Reports Third Quarter 2022 Financial Results

GlobeNewswire November 10, 2022

Aspira Women's Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10

GlobeNewswire November 1, 2022

Aspira Women's Health to Participate at the Upcoming MicroCap Rodeo Windy City Roundup 2022

GlobeNewswire October 6, 2022

Aspira Women's Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference

GlobeNewswire October 5, 2022